Seroprevalence of and Risk Factors for Toxoplasma gondii among Pregnant Women in Abyek Township of Qazvin Province , Iran (2013)

  • Fatemeh Tabatabaie
  • Morteza Mafi
  • Mohsen Golestani
  • Narges Shahmohammad
  • Hadi Mafi
  • Fatemeh Maleki

Abstract

 

Objective: Toxoplasmosis is an important disease which is caused by the coccidian parasite Toxoplasma gondii. The aim of this study was to determine
seroprevalence of and risk factors for T. gondii among pregnant women in Abyek township of Qazvin province by enzyme-linked immunosorbent
assay method.
Methods: Blood samples were taken from 200 pregnant women referred to the health centers of Abyek township. Immunoglobulin M (IgM)and IgG
titers and effects of some factors on incidence of the disease were evaluated. The collected data were statistically analyzed with SPSS 17 using Chisquare
test.
Results: Anti toxoplasma IgM and IgG were positive in 2% and 29% respectively. Seropositive subjects were more frequently seen in women with
age >30 years compared to younger women. No significant relationship was found between the seroprevalence of T. gondii infection and level of
education, residence area, history of abortion and gestational age.
Conclusion: It was indicative of having a latent infection due to the previous exposure to toxoplasma parasite in this region.
Keywords: Toxoplasma gondii, Prevalence, Pregnant women, Enzyme-linked immunosorbent assay, Immunoglobulin M.

References

1. Krick JA, Remington JS. Toxoplasmosis in the adult – An overview. N Engl J Med 1978;298(10):550-3.
2. Dubey JP, Beattie CP. Toxoplasmosis of Animal and Man. Boca Raton, FL: CRC Press; 1988. p. 1-220.
3. Saeedi M, Veghari GR, Marjani A. Seroepidemiologic evaluation of anti-toxoplasma antibodies among women in north of Iran. Pak J Biol Sci 2007;10(14):2359-62.
4. Youssefi MR, Sefidgar AA, Mostafazadeh A, Omran SM. Serologic evaluation of toxoplasmosis in matrimonial women in Babol, Iran. Pak J Biol Sci 2007;10(9):1550-2.
5. Sharif M, Ajami A, Daryani A, Ziaei H, Khalilian A. Serological survey of toxoplasmosis in women referred to medical health laboratory before marriage northern Iran. Int J Mol Med Adv Sci 2006;2(2):134-7.
6. Fallah M, Rabiee S, Matini M, Taherkhani H. Seroepidemiology of toxoplasmosis in primigravida women in Hamadan, Islamic Republic of Iran, 2004. East Mediterr Health J 2008;14(1):163-71.
7. Hashemi HJ, Saraei M. Seroprevalence of Toxoplasma gondii in unmarried women in Qazvin, Islamic Republic of Iran. East Mediterr Health J 2010;16(1):24-8.
8. Fallah M, Rabiee S, Matini M, Taherkhani H. Seroepidemiology of Toxoplasma infection in women aged 15-45 years in Hamadan west of Iran. J Res Health Sci 2003;3(1):9-12.
9. Mansoori FL. Seroepidemiology of toxoplasmosis in Kermanshah province west of Iran. Behboud 2004;7(2):12-9.
10. Abdi J, Shojaee S, Mirzaee A, Keshavarz H. Seroprevalence of toxoplasmosis in pregnant women in Ilam province Iran. Iran J Parasitol 2008;3(2):34-7.
11. Sharifi Mood B, Hashemi Shahri M, Salehi M, Naderi M, Naser Poor T. Seroepidemiology of Toxoplasma infection in the pregnant women in Zahedan, Southeast of Iran. J Res Health Sci 2006;6(1):1-3.
12. Fouladvand M, Barazesh A, Naeimi B, Zandi K, Tajbakhsh S. Seroprevalence of toxoplasmosis in high school girls in Bushehr city South-west of Iran 2009. Afr J Microbiol Res 2010;4(11):1117-21.
13. Manouchehri Naeini K, Deris F, Zebardast N. The immunity status of the rural pregnant women in Chaharmahal and Bakhtyari province against Toxoplasma infection 200-2002. J Shahrekord Med Sci 2004;6(3):63-72.
14. Keshavarz Valian H, Nateghpour M, Zibaee M. Seroepidemiology of toxoplasmosis in Karaj Iran in 1998. Iran J Public Health 1998;27(3‑4):73-8.
15. Keshavarz Valian H, Mamishi S, Daneshvar H. Prevalevce of toxplasmosis in hospitalized patient of Kerman hospitals Iran. J Med Sci Kerman 2000;7(2):126-39.
16. Arbabi M, Talari SA. Seroprevalence of Toxoplasma infection in pregnant women in Kashan Iran. Feiz J 2001;22:28-38.
17. Nash JQ, Chissel S, Jones J, Warburton F, Verlander NQ. Risk factors for toxoplasmosis in pregnant women in Kent, United Kingdom. Epidemiol Infect 2005;133(3):475-83.
18. Jones JL, Kruszon-Moran D, Wilson M, McQuillan G, Navin T, McAuley JB. Toxoplasma gondii infection in the United States:Seroprevalence and risk factors. Am J Epidemiol 2001;154(4):357-65.
19. Ertug S, Okyay P, Turkmen M, Yuksel H. Seroprevalence and risk factors for Toxoplasma infection among pregnant women in Aydin province, Turkey. BMC Public Health 2005;5:66.
20. Mostafavi SN, Ataei B, Nokhodian Z, Yaran M, Babak A. Seroepidemiology of Toxoplasma gondii infection in Isfahan province, central Iran: A population based study. J Res Med Sci 2011;16(4):496‑501.
21. Lebech M, Larsen SO, Petersen E. Prevalence, incidence and geographical distribution of Toxoplasma gondii antibodies in pregnant women in Denmark. Scand J Infect Dis 1993;25(6):751-6.
22. Ades AE, Parker S, Gilbert R, Tookey PA, Berry T, Hjelm M, et al. Maternal prevalence of Toxoplasma antibody based on anonymous neonatal serosurvey: A geographical analysis. Epidemiol Infect 1993;110(1):127-33.
23. Fallahi SH, Badparva E, Mohammadi M, Ebr-ahimzadeh F, Pournia Y. Seroepidemiological study of Toxoplasma gondii in women referred to Khorramabad laboratory of health center for medical examination before marriage, Lorestan Province, Iran, 2007. Asian J Biol Sci 2009;2(3):88-94. Available from: http://www.journals.mui.ac.ir/jrms.
24. Ataeian A, Tadayon P. Prevalence of Toxoplasma gondii antibodies in women of Zanjan Hakim Hidajy hospital. J Zanjan Med Sci 2000;8(32):4-11.
25. Sharma P, Gupta I, Ganguly NK, Mahajan RC, Malla N. Increasing Toxoplasma seropositivity in women with bad obstetric history and in newborns. Natl Med J India 1997;10(2):65-6.
26. Ghorbani M, Farzaneh I, Voshtani H, Rezaian M. Congenital toxoplasmosis. Iran J Publ Health 1977;6:1-5.
27. Yasodhara P, Ramalakshmi BA, Lakshmi V, Krishna TP. Socioeconomic status and prevalence of toxoplasmosis during pregnancy. Indian J Med Microbiol 2004;22(4):241-3.
28. Diaz-Suárez O, Estevez J. Seroepidemiology of toxoplasmosis in women of childbearing age from a marginal community of Maracaibo, Venezuela. Rev Inst Med Trop Sao Paulo 2009;51:13-7.
29. Punda-Polic V, Tonkic M, Capkun V. Prevalence of antibodies to Toxoplasma gondii in the female population of the County of Split Dalmatia, Croatia. Eur J Epidemiol 2000;16(9):875-7.
30. Assmar M, Amirkhani A, Piazak N, Hovanesian A, Kooloobandi A, Etessami R. Toxoplasmosis in Iran. Results of a seroepidemiological study. Bull Soc Pathol Exot 1997;90:19-21.
31. Bonilla LC, Chavez YS, Estevez J, Larreal Y, Molero E. Prevalence of human toxoplasmosis in San Carlos Island Venezuela. Interciencia 2003;28(8):457-62.
Statistics
246 Views | 498 Downloads
How to Cite
Tabatabaie, F., M. Mafi, M. Golestani, N. Shahmohammad, H. Mafi, and F. Maleki. “Seroprevalence of and Risk Factors for Toxoplasma Gondii Among Pregnant Women in Abyek Township of Qazvin Province , Iran (2013)”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 8, no. 1, Jan. 2015, pp. 280-2, https://innovareacademics.in/journals/index.php/ajpcr/article/view/3283.
Section
Original Article(s)